Neuromeka Patents – Key Insights and Stats

Neuromeka has a total of 68 patents globally, out of which 41 have been granted. Of these 68 patents, more than 79% patents are active. Korea (South) is where Neuromeka has filed the maximum number of patents, followed by the United States of America and Europe. Parallelly, Korea (South) seems to be the main focused R&D centre and also is the origin country of Neuromeka.

Neuromeka was founded in 2013. Neuromeka is a firm that provides embedded robot controllers. By utilizing a real-time embedded robot controller based on fieldbus, a gateway and IoT sensor, control software, and smart linked technology, the company offers robot and HRI interface.

Do read about some of the most popular patents of Neuromeka which have been covered by us in this article and also you can find Neuromeka patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Neuromeka patent portfolio.

How many patents do the Founder and CEO of Neuromeka have?

The Founder and CEO Jonghoon Park have 0 patents.

How many patents does Neuromeka have?

Neuromeka has a total of 68 patents globally. These patents belong to 39 unique patent families. Out of 68 patents, 54 patents are active.

How Many Patents did Neuromeka File Every Year?

Neuromeka Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantNeuromeka Applications FiledNeuromeka Patents Granted
20234
2022513
202195
20202811
201910
201833
201732
201651
20152
201411
201311
20111

How many Neuromeka patents are Alive/Dead?

Worldwide Patents

Neuromeka Patent Portfolio

How Many Patents did Neuromeka File in Different Countries?

Neuromeka Worldwide Patent Filing

Countries in which Neuromeka Filed Patents

CountryPatent
Korea (South)47
United States Of America6
Europe5

Where are Research Centers of Neuromeka Patents Located?

The Research Centers of Neuromeka Patents Korea (South).

10 Best Neuromeka Patents

US20180020410A1 is the most popular patent in the Neuromeka portfolio. It has received 23 citations so far from companies like Qualcomm, Intel, HP.

Below is the list of 10 most cited patents of Neuromeka:

Publication NumberCitation Count
US20180020410A123
KR101716855B113
KR102170591B16
KR101794700B15
WO2021086106A15
KR101461627B15
KR102226122B13
KR101876845B13
KR101632370B13
KR102177445B12

What are Neuromeka key innovation segments?

What Technologies are Covered by Neuromeka?

The chart below distributes patents filed by Neuromeka in different countries on the basis of the technology protected in patents. It also represents the markets where Neuromeka thinks it’s important to protect particular technology inventions.

R&D Focus: How has Neuromeka search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Neuromeka?

Related Articles

Actome Patents – Insights & Stats (Updated 2024)

Actome has a total of 30 patents globally, out of which 12 have been granted. Of these 30 patents, more than 93% patents are active. United States of America is where Actome has filed the maximum number of patents, followed by Europe (EPO) and Singapore. Parallelly, Germany seems to be

Read More »

1s1 Energy Patents – Insights & Stats (Updated 2024)

1s1 Energy has a total of 36 patents globally, out of which 6 have been granted. Of these 36 patents, more than 86% patents are active. United States of America is where 1s1 Energy has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.